21 We believe that effective corporate governance ensures transparency, which supports a strong and balanced sustainable growth. We also believe that a strong Governance structure and mechanism contributes to the effectiveness of an organization. The Board of Directors is the apex and highest governing body at Sai Life Sciences. The Board along with its Committees provides leadership and strategic guidance to the company’s management and ensures that the management adheres to high standards of ethics, transparency and disclosures. The Board’s objective is to create sustainable value for all stakeholders, provide vision to the company and oversee implementation of the Board’s decisions. Board of directors The Board comprises Executive and Non-Executive Directors that include independent professionals. The primary role of the Board is that of trusteeship to protect and enhance shareholder value through strategic oversight of Sai and its wholly owned subsidiaries. As trustees, the Board ensures that the Company has clear goals aligned to shareholder value and its growth. The Board sets strategic goals and seeks accountability for their fulfilment. The Board, as part of its functioning, annually reviews its role and also evaluates the performance of the Directors and the Board Committees. The constitution of the Board of the Company requires the Board to have a balance of skills, experience and diversity of perspectives appropriate to the Company. The Chief Operating Officer (COO) is responsible for smooth functioning of the Company’s respective businesses. This also includes development of business strategies as well as due consideration of the interests of all the stakeholders. The business strategies and plans are reviewed during the annual strategy meet by the CEO, COO and various business heads of the Company. The Independent Directors constitute nearly one third of the Board’s strength, thus ensuring independence and transparency of the Board’s decision-making process. The Independent Directors are not associated with the Company in any executive capacity. The present strength of the Board is seven, including the Chairman, Managing Director, two Investor representative Directors and three Non-Executive Directors, of which two are Independent directors, one of whom is a Women Director. The board meets a minimum of four times a year to discuss key issues and the performance.
RkJQdWJsaXNoZXIy MTIwMDc4NQ==